Table of contents
September 2004 Vol 4 No 9
In this issue
p655 | doi:10.1038/nrc1439
Research Highlights
Angiogenesis: A complex picture
p657 | doi:10.1038/nrc1438
In the news
Refined tastes linked to breast cancer
p658 | doi:10.1038/nrc1444
Tumorigenesis: Specific non-cooperation
p658 | doi:10.1038/nrc1447
In brief
Targeted therapy | Cancer risk | Tumour suppressors | Chemotoxicity
p659 | doi:10.1038/nrc1443
Gene therapy: Means to an end
p659 | doi:10.1038/nrc1448
Hypoxia: Structural disruption
p660 | doi:10.1038/nrc1436
Breast cancer: Getting to know the neighbours
p660 | doi:10.1038/nrc1437
Signal transduction: Time for a 'signal-o-some'?
p661 | doi:10.1038/nrc1446
Cachexia: A bit of muscle
p662 | doi:10.1038/nrc1442
Therapeutics: Pinch hitter
p662 | doi:10.1038/nrc1445
Immunotherapy: Self-improvement
p663 | doi:10.1038/nrc1449
Trial Watch
Taking a slug at cancer | Profiling ALL drug resistance
p663 | doi:10.1038/nrc1450
Reviews
BRCA1 and BRCA2: 1994 and beyond
Steven A. Narod & William D. Foulkes
p665 | doi:10.1038/nrc1431
Nuclear structure in cancer cells
Daniele Zink, Andrew H. Fischer & Jeffrey A. Nickerson
p677 | doi:10.1038/nrc1430
Oncogenic mechanisms of the Helicobacter pylori CagA protein
Masanori Hatakeyama
p688 | doi:10.1038/nrc1433
Gallbladder cancer: lessons from a rare tumour
Ignacio I. Wistuba & Adi F. Gazdar
p695 | doi:10.1038/nrc1429
Gene-promoter hypermethylation as a biomarker in lung cancer
Steven A. Belinsky
p707 | doi:10.1038/nrc1432
Perspectives
Opinion
Switching on kinases: oncogenic activation of BRAF and the PDGFR family
Nick J. Dibb, Stephen M. Dilworth & Clifford D. Mol
p718 | doi:10.1038/nrc1434
Opinion
Transcription — guarding the genome by sensing DNA damage
Mats Ljungman & David P. Lane
p727 | doi:10.1038/nrc1435
Timeline
Radiation oncology: a century of achievements
Jacques Bernier, Eric J. Hall & Amato Giaccia
p737 | doi:10.1038/nrc1451
Erratum: Chemical-induced DNA damage and human cancer risk
Miriam C. Poirier
p747 | doi:10.1038/nrc1441